At the world’s premier arthritis conference, the American College of Rheumatology Annual Meeting (ACR), taking place in San Diego on November 3rd-8th, leading investigators from the United States, Canada and Egypt will present new data on the 14-3-3η blood test. Several of these studies grow the body of evidence of 14-3-3η’s important role as an early diagnostic test that assists with rheumatoid arthritis patient management along the disease course. As a highlight of these new data are two studies describing how 14-3-3η testing can assist with arthritis diagnosis in children. Juvenile Idiopathic Arthritis (JIA) is an ambiguous disease, with several subtypes, that new blood tests like 14-3-3η can help better characterize. As a marker of joint damage progression risk, it is expected that 14-3-3η will have an increasingly important role in the management of multiple types of arthritis.
List of 14-3-3η ACR/ARHP 2017 Conference Proceedings
[custom_table style=”1″]
| Title | Date & Time |
|---|---|
| Evaluation of Synovial Fluid 14-3-3η Protein as a Marker of Joint Damage in Rheumatoid Arthritis Patients Authors: Nevin Hammam, Shaimaa Salah, Anthony Marotta and Emad F. Kholef Abstract Number: 1366 |
November 6th, 9:00am Poster Hall C |
| 14-3-3η: Useful for More Than the Diagnosis of Rheumatoid Arthritis Authors: Lisa Zickuhr, Maryam Pourpaki, Martha M. Brooks and Amy Joseph Abstract Number: 1355 |
November 6th, 9:00am Poster Hall C |
| Prevalance of Serum 14-3-3η (eta) in Juvenile Idiopathic Arthritis Authors: Iris Reyhan, Olga S. Zhukov, Robert J. Lagier, Robert Bridgforth, Gary J Williams, Joanna M. Popov, Stanley J. Naides and Andreas Reiff Abstract Number: 2312 |
November 7th, 9:00am Poster Hall C |
| 14-3-3η (eta) Protein in Juvenile Idiopathic Arthritis (JIA) Patients Authors: Austin M. Dalrymple, Paul Tuttle IV, Lance Feller, Olga S. Zhukov, Robert J. Lagier, Robert Bridgforth, Gary J Williams, Joanna M. Popov, Stanley J. Naides and Terry Moore Abstract Number 2327 |
November 7th, 9:00am Poster Hall C |
[/custom_table]
- Labcorp: Booth No. 1034
- RDL Reference Laboratory: Booth No. 1939
The 14-3-3η blood test is available in the U.S through Labcorp and RDL Reference Laboratory. JOINTstat™ (14-3-3η) is CE marked and TGA approved for clinical use in Europe and Australia. In Canada, the test is available through LifeLabs and in Japan through Medical & Biological Laboratories (MBL).
For more information on the 14-3-3η test and Augurex Life Sciences Corp, visit www.augurex.com or www.jointstat.com.